Physician profile
Dunya M Atisha
NPI 1679694400
$74,281.13
in general payments reported to CMS, 2019-2025
15 companies · $49K in 2025
The $49K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,120 · 2020: $258 · 2021: $123 · 2022: $305 · 2023: $12K · 2024: $12K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $63K · Travel and Lodging: $5,953 · Food and Beverage: $3,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,550.00 |
| Travel and Lodging | $5,952.84 |
| Food and Beverage | $3,972.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $68,404.75 | 2019-2025 | |
| Axogen | $2,091.86 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Biocircuit Technologies INC | $1,318.42 | 2025 | Nerve Tape |
| Mentor Worldwide LLC | $890.82 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $265.07 | 2020-2022 | |
| Somavac Medical Solutions, INC. | $209.43 | 2025 | Somavac 100 Sustained Vacuum System |
| Solventum Corporation | $185.90 | 2024-2025 | Prevena, Promogran Prisma, Activ.A.C. |
| Smith+Nephew, INC. | $148.82 | 2024 | Grafix Pl, Stravix |
| Kerecis Limited | $147.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bard Peripheral Vascular, INC. | $123.45 | 2021 | |
| Tepha INC | $122.97 | 2019 | |
| Heron Therapeutics, INC. | $122.93 | 2025 | Zynrelef |
| Motiva USA, LLC | $115.21 | 2025 | |
| Tela Bio, INC. | $112.56 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $21.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dunya Atisha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.